NORMISON

This brand name is authorized in Australia, New Zealand, South Africa

Active ingredients

The drug NORMISON contains one active pharmaceutical ingredient (API):

1 Temazepam
UNII CHB1QD2QSS - TEMAZEPAM

Temazepam is a benzodiazepine with hypnotic and sedative effects as well as anxiolytic activity. Temazepam effects are likely to be due to potentiation of gamma-aminobutyric acid (GABA), although other neurotransmitters may also be affected.

Read about Temazepam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CD07 Temazepam N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2088X, 2089Y, 5221T, 5375X
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12109
Country: ZA Health Products Regulatory Authority Identifier(s): L/2.2/125, M/2.2/205

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.